Endovascular

View the latest content related to this topic

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

While the exact mechanism is unknown, the data suggest a multitude of benefits independent of large weight loss.

L.A. McKeown

March 29, 2025

Slides

See all

Presentation ACC 2025

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Presenter: Marc P. Bonaca

March 29, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

Presentation Cardiovascular Interventions 2024

Building Your PERT Team: Designing the Right Team with the Right Technology

Presenter: Curtiss T. Stinis

November 11, 2024

Presentation TCT 2024

CATRX Data, Product Overview & Case Presentations

Presenter: George S. Chrysant

October 30, 2024

Presentation TCT 2024

Risk of Hemolysis & Implications of Returning Unwashed Shed Blood

Presenter: Suhail Dohad

October 30, 2024

News

See all

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

By Caitlin E. Cox

April 01, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

By L.A. McKeown

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

By Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

By Michael O'Riordan

March 26, 2025

News Daily News

SONOBIRDIE: Ultrasound Appears to Make Carotid Endarterectomy Safer

By Todd Neale

March 25, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Endovascular

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Slides

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Building Your PERT Team: Designing the Right Team with the Right Technology

CATRX Data, Product Overview & Case Presentations

Risk of Hemolysis & Implications of Returning Unwashed Shed Blood

News

TCTMD’s Top 10 Most Popular Stories for March 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

SONOBIRDIE: Ultrasound Appears to Make Carotid Endarterectomy Safer

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Endovascular

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content